BioSpace News Archive

Jill Fiedler-Kelly named President along with other promotions and key additions

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced it has entered into a lease agreement to build an approximately 22,000 square foot facility in Rockville, Maryland

General Healthcare Resources Brand Sees Strong Year-Over-Year Growth

Nektar Therapeutics (Nasdaq: NKTR) today announced the acceptance of five clinical and preclinical data abstracts for its immuno-oncology portfolio at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting.

IASO Biotherapeutics announced that IASO BIO has received National Medical Products Administration approval for an Investigational New Drug Application for CT103A—an innovative therapy for the treatment of relapsed refractory multiple myeloma patients.

PANTHERx is excited to announce that it is the first pharmacy nationwide that has been awarded the Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care.

MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions for oncology, announced the release of MMPower v4, the latest update to its Clinical Decision Support platform

CNSI, a leading business solutions provider in developing and delivering innovative health information technology solutions, announced today that David Adams has joined the company as Executive Vice President and Chief Financial Officer (CFO)

Vivante Health, creators of the GIThrive all-in-one digital gut health program, earned a spot on the inaugural Digital Health 150, CB Insights’ showcase of the most promising digital health companies in the world.

ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced it completed $15 million in financing and that medical device industry veterans Ryan Drant and Tim Patrick have joined its board of directors.